公开(公告)号：US20220204972A1

公开(公告)日：2022-06-30

申请号：US17552372

申请日：2021-12-16

Applicant: Stichting Katholieke Universiteit

Inventor： Robert Wilhelmus Johanna Collin ,  Alejandro Garanto Iglesias ,  Franciscus Peter Maria Cremers ,  Silvia Albert

IPC: C12N15/113 ,  A61K9/00

Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.

公开(公告)号：US11236333B2

公开(公告)日：2022-02-01

申请号：US16465405

申请日：2017-12-13

Applicant: STICHTING KATHOLIEKE UNIVERSITEIT

Inventor： Robert Wilhelmus Johanna Collin ,  Alejandro Garanto Iglesias ,  Franciscus Peter Maria Cremers ,  Silvia Albert

IPC: C07H21/04 ,  C12N15/113 ,  A61K9/00

Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.

公开(公告)号：US11739324B2

公开(公告)日：2023-08-29

申请号：US16451101

申请日：2019-06-25

Applicant: Stichting Katholieke Universiteit

Inventor： Robert Wilhelmus Johanna Collin ,  Alejandro Garanto Iglesias ,  Franciscus Peter Maria Cremers

IPC: C12N15/113 ,  A61K9/00

CPC classification number: C12N15/113 ,  A61K9/0048 ,  C12N2310/11 ,  C12N2310/315 ,  C12N2310/321 ,  C12N2320/32

Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease

公开(公告)号：US12054716B2

公开(公告)日：2024-08-06

申请号：US17552372

申请日：2021-12-16

Applicant: Stichting Katholieke Universiteit

Inventor： Robert Wilhelmus Johanna Collin ,  Alejandro Garanto Iglesias ,  Franciscus Peter Maria Cremers ,  Silvia Albert

IPC: C07H21/04 ,  A61K9/00 ,  C12N15/113

CPC classification number: C12N15/113 ,  A61K9/0048 ,  C12N2310/11 ,  C12N2310/315 ,  C12N2310/321 ,  C12N2310/346 ,  C12N2320/32 ,  C12N2320/33

Abstract: The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.